RESEARCH-USE BIOSIMILAR ANTIBODY
Nofazinlimab
Monoclonal antibody · IgG4
Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab shows antitumor activity and can be used for the research of unresectable or metastatic hepatocellular carcinoma.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-334
CATALOG NUMBERSC-BS-334
MOLECULAR WEIGHTApprox. 145.08 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab shows antitumor activity and can be used for the research of unresectable or metastatic hepatocellular carcinoma.
Nofazinlimab is a recombinant research-use antibody directed against PDCD1.